James Cavanaugh

James Cavanaugh

Direktor/Vorstandsmitglied bei
SkinMedica, Inc.

Vermögen: 562 647 $ am 30.09.2026

89 Jahre
Health Technology
Commercial Services
Finance

Profil

James H.
Cavanaugh
is currently Director at Diacrin, Inc. (Delaware) and SkinMedica, Inc. He is Managing Director & Senior Advisor at HealthCare Ventures LLC since 1989.
He serves as Trustee at the Gerald R.
Ford Presidential Foundation.
Formerly, Dr. Cavanaugh was Non-Executive Chairman at Shire Plc; Chairman at Diversa Corp., Vicuron Pharmaceuticals LLC, CardioKine, Inc., The Richard Nixon Foundation, Shire Acquisition, Inc. (1999–2008), and Verenium Corp.
(1992–2013).
He was Director at MedImmune LLC (2007), Middlebrook Pharmaceuticals, Inc. (1999–2010), PharmAthene, Inc. (2007–2011), Colorescience Corp., Unihealth America, Inc., Nixon Group, Senseonics, Inc., Xanodyne Pharmaceuticals, Inc., Orqis Medical Corp., Healthcare Acquisition Corp., Pharmaceutical Research & Manufacturers Association, National Venture Capital Association, Consumer Healthcare Products Association, and others.
He was Founding Director at Marine National Bank (Irvine, California).
He held leadership roles including President at Smithkline Beckman Corp, Smithkline & French Laboratories US, Inc. (1985–1989), Smithkline Clinical Laboratories (1981–1985), French Laboratories U.S., Inc. (1989), Allergan Sales LLC, and Allergan International.
He served as Deputy Director at Domestic Policy Council and Deputy Assistant Secretary at the US Department of Health & Human Services.
He was Independent Director at Cypherpunk Technologies, Inc. (2016–2026).
Education includes an undergraduate degree from Fairleigh Dickinson University (1959), a graduate degree from the University of Iowa (1961), and a doctorate from the University of Iowa (1964).

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
20.04.2026 168’963 ( 0.16% ) 562 647 $ 30.09.2026

Aktive Positionen von James Cavanaugh

UnternehmenPositionBeginn
Berater -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von James Cavanaugh

UnternehmenPositionEnde
CYPHERPUNK TECHNOLOGIES INC. Direktor/Vorstandsmitglied 18.06.2026
VERENIUM CORP Vorsitzender 31.10.2013
Direktor/Vorstandsmitglied 25.04.2011
Direktor/Vorstandsmitglied 20.03.2010
Vorsitzender 23.05.2008
Sehen Sie sich die Erfahrung von James Cavanaugh im Detail an

Ausbildung von James Cavanaugh

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

77

Beziehungen ersten Grades

38

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen38

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Retail Trade

Finance

Finance

Finance

Commercial Services

Health Technology

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Health Services

Finance

Government

Government

Commercial Services

Commercial Services

Pharmaceutical Research & Manufacturers Association

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Smithkline & French Laboratories US, Inc.

Smithkline Clinical Laboratories

Distribution Services

French Laboratories U.S., Inc.

Health Technology

Finance

  1. Börse
  2. Insiders
  3. James Cavanaugh